146 related articles for article (PubMed ID: 15548526)
1. Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist.
de Mendonça FL; da Fonseca PC; Phillips RM; Saldanha JW; Williams TJ; Pease JE
J Biol Chem; 2005 Feb; 280(6):4808-16. PubMed ID: 15548526
[TBL] [Abstract][Full Text] [Related]
2. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.
Mirzadegan T; Diehl F; Ebi B; Bhakta S; Polsky I; McCarley D; Mulkins M; Weatherhead GS; Lapierre JM; Dankwardt J; Morgans D; Wilhelm R; Jarnagin K
J Biol Chem; 2000 Aug; 275(33):25562-71. PubMed ID: 10770925
[TBL] [Abstract][Full Text] [Related]
3. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation.
Pease JE; Wang J; Ponath PD; Murphy PM
J Biol Chem; 1998 Aug; 273(32):19972-6. PubMed ID: 9685332
[TBL] [Abstract][Full Text] [Related]
4. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.
Sabroe I; Peck MJ; Van Keulen BJ; Jorritsma A; Simmons G; Clapham PR; Williams TJ; Pease JE
J Biol Chem; 2000 Aug; 275(34):25985-92. PubMed ID: 10854442
[TBL] [Abstract][Full Text] [Related]
5. Identification of the extracellular loop 2 as the point of interaction between the N terminus of the chemokine MIP-1alpha and its CCR1 receptor.
Zoffmann S; Chollet A; Galzi JL
Mol Pharmacol; 2002 Sep; 62(3):729-36. PubMed ID: 12181451
[TBL] [Abstract][Full Text] [Related]
6. Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation.
Vaidehi N; Schlyer S; Trabanino RJ; Floriano WB; Abrol R; Sharma S; Kochanny M; Koovakat S; Dunning L; Liang M; Fox JM; de Mendonça FL; Pease JE; Goddard WA; Horuk R
J Biol Chem; 2006 Sep; 281(37):27613-20. PubMed ID: 16837468
[TBL] [Abstract][Full Text] [Related]
7. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
[TBL] [Abstract][Full Text] [Related]
8. CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases.
Gladue RP; Tylaska LA; Brissette WH; Lira PD; Kath JC; Poss CS; Brown MF; Paradis TJ; Conklyn MJ; Ogborne KT; McGlynn MA; Lillie BM; DiRico AP; Mairs EN; McElroy EB; Martin WH; Stock IA; Shepard RM; Showell HJ; Neote K
J Biol Chem; 2003 Oct; 278(42):40473-80. PubMed ID: 12909630
[TBL] [Abstract][Full Text] [Related]
9. Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation.
Wise EL; Duchesnes C; da Fonseca PC; Allen RA; Williams TJ; Pease JE
J Biol Chem; 2007 Sep; 282(38):27935-43. PubMed ID: 17635911
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor.
Hesselgesser J; Ng HP; Liang M; Zheng W; May K; Bauman JG; Monahan S; Islam I; Wei GP; Ghannam A; Taub DD; Rosser M; Snider RM; Morrissey MM; Perez HD; Horuk R
J Biol Chem; 1998 Jun; 273(25):15687-92. PubMed ID: 9624164
[TBL] [Abstract][Full Text] [Related]
11. Site-directed mutagenesis of CCR2 identified amino acid residues in transmembrane helices 1, 2, and 7 important for MCP-1 binding and biological functions.
Gavrilin MA; Gulina IV; Kawano T; Dragan S; Chakravarti L; Kolattukudy PE
Biochem Biophys Res Commun; 2005 Feb; 327(2):533-40. PubMed ID: 15629146
[TBL] [Abstract][Full Text] [Related]
12. Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.
Tian Y; New DC; Yung LY; Allen RA; Slocombe PM; Twomey BM; Lee MMK; Wong YH
Eur J Immunol; 2004 Mar; 34(3):785-795. PubMed ID: 14991608
[TBL] [Abstract][Full Text] [Related]
13. Molecular approaches to identifying ligand binding and signaling domains of C-C chemokine receptors.
Monteclaro FS; Arai H; Charo IF
Methods Enzymol; 1997; 288():70-84. PubMed ID: 9356988
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1beta.
Chou CC; Fine JS; Pugliese-Sivo C; Gonsiorek W; Davies L; Deno G; Petro M; Schwarz M; Zavodny PJ; Hipkin RW
Br J Pharmacol; 2002 Nov; 137(5):663-75. PubMed ID: 12381680
[TBL] [Abstract][Full Text] [Related]
15. Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor.
Liang M; Rosser M; Ng HP; May K; Bauman JG; Islam I; Ghannam A; Kretschmer PJ; Pu H; Dunning L; Snider RM; Morrissey MM; Hesselgesser J; Perez HD; Horuk R
Eur J Pharmacol; 2000 Feb; 389(1):41-9. PubMed ID: 10686294
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional analysis of Ccr1l1, a Rodentia-restricted eosinophil-selective chemokine receptor homologue.
Kline JM; Heusinkveld LE; Taranto E; Martin CB; Tomasi AG; Hsu IJ; Cho K; Khillan JS; Murphy PM; Pontejo SM
J Biol Chem; 2021; 296():100373. PubMed ID: 33548230
[TBL] [Abstract][Full Text] [Related]
17. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of chemically synthesized derivatives of the human CC chemokine CCL15/HCC-2, a high affinity CCR1 ligand.
Escher SE; Forssmann U; Frimpong-Boateng A; Adermann K; Vakili J; Sticht H; Detheux M
J Pept Res; 2004 Jan; 63(1):36-47. PubMed ID: 14984572
[TBL] [Abstract][Full Text] [Related]
19. Impact of engagement of FcepsilonRI and CC chemokine receptor 1 on mast cell activation and motility.
Toda M; Dawson M; Nakamura T; Munro PM; Richardson RM; Bailly M; Ono SJ
J Biol Chem; 2004 Nov; 279(46):48443-8. PubMed ID: 15337751
[TBL] [Abstract][Full Text] [Related]
20. Small molecule antagonist of C-C chemokine receptor 1 (CCR1) reduces disc inflammation in the rabbit model.
Chou PH; Chee A; Shi P; Lin CL; Zhao Y; Zhang L; An HS
Spine J; 2020 Dec; 20(12):2025-2036. PubMed ID: 32673730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
